Manifold Bio is an AI-driven protein engineering company developing tissue-targeted biologics with a focus on central nervous system (CNS) delivery for neurodegenerative diseases.
Manifold Bio's tagline is "Organism-scale intelligence, designed in vivo." The company's mission is creating tissue-targeted biologics while building the "virtual organism"—a predictive model of living systems that integrates high-throughput in vivo data.
Manifold Bio has developed the mDesign Engine, which combines AI-guided protein design with in vivo testing capabilities. Key features include:
Manifold Bio collaborates with NVIDIA for million-scale experimental validation of AI-driven protein binder design, leveraging GPU-accelerated computing for protein structure prediction and design.
Manifold Bio's mShuttle portfolio targets brain-specific delivery:
Manifold Bio has a strategic collaboration with Roche to develop multiple next-generation brain shuttles for neurological diseases. This partnership leverages Roche's development and commercialization expertise with Manifold Bio's mShuttle technology for blood-brain barrier crossing.
Manifold Bio's platform addresses several critical challenges in developing therapeutics for Alzheimer's disease and Parkinson's disease:
BBB Penetration: The mShuttle technology enables delivery of biologics across the blood-brain barrier, a major hurdle in CNS drug development
Protein Engineering: AI-driven design of antibody therapeutics with optimized binding affinity and pharmacokinetics
Oligonucleotide Delivery: Development of brain-targeted oligonucleotides for gene silencing approaches in neurodegenerative diseases
Tissue Specificity: Platform enables targeting specific tissues while detargeting others, reducing off-target effects
| Company | Focus | Differentiation |
|---|---|---|
| Manifold Bio | In vivo validation, brain shuttles | Direct testing in living systems, BBB crossing |
| Generate Biomedicines | Protein generation | Generates novel protein scaffolds |
| Absci | Antibody design | AI + synthetic biology platform |
| Evotec | Drug discovery services | Broad platform, multiple partnerships |